{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:37:03Z","timestamp":1792827423180,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mathematical Biosciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mbs.2026.109830","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:57:19Z","timestamp":1792249039000},"page":"109830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A mechanistic learning framework for breast cancer relapse prediction"],"prefix":"10.1016","volume":"402","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-075X","authenticated-orcid":false,"given":"Judith","family":"P\u00e9rez-Vel\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-6225","authenticated-orcid":false,"given":"Meltem","family":"G\u00f6lgeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2003-7567","authenticated-orcid":false,"given":"\u0130brahim","family":"Kula\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mbs.2026.109830_bib0001","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA: Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.mbs.2026.109830_bib0002","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.mbs.2026.109830_bib0003","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2015.73","article-title":"Clinical management of breast cancer heterogeneity","volume":"12","author":"Zardavas","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6797","key":"10.1016\/j.mbs.2026.109830_bib0004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mbs.2026.109830_bib0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.mbs.2026.109830_bib0006","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0007","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.mbs.2026.109830_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol."},{"issue":"7586","key":"10.1016\/j.mbs.2026.109830_bib0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mbs.2026.109830_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","article-title":"The lingering mysteries of metastatic recurrence in breast cancer","volume":"124","author":"Riggio","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.mbs.2026.109830_bib0011","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V","volume":"34","author":"Colleoni","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.mbs.2026.109830_bib0012","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.mbs.2026.109830_bib0013","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","article-title":"The dormant cancer cell life cycle","volume":"20","author":"Phan","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc.: B"},{"issue":"3","key":"10.1016\/j.mbs.2026.109830_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bjc.1982.62","article-title":"A prognostic index in primary breast cancer","volume":"45","author":"Haybittle","year":"1982","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mbs.2026.109830_bib0016","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/bjc.2012.338","article-title":"PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2","volume":"107","author":"Wishart","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.mbs.2026.109830_bib0017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12885-019-5442-6","article-title":"Prognostic models for breast cancer: a systematic review","volume":"19","author":"Phung","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1308\/003588414X14055925060514","article-title":"The nottingham prognostic index: five- and ten-year data for all-cause survival within a screened population","volume":"97","author":"Fong","year":"2015","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"10.1016\/j.mbs.2026.109830_bib0019","unstructured":"C. Health, National Institute for and Excellence, Early and locally advanced breast cancer: diagnosis and management. NICE guideline NG101, 2018, (https:\/\/www.nice.org.uk\/guidance\/ng101). Published 18 July 2018, last updated 14 April 2025; accessed 20 September 2026."},{"issue":"282","key":"10.1016\/j.mbs.2026.109830_bib0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"issue":"9318","key":"10.1016\/j.mbs.2026.109830_bib0021","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0140-6736(02)08594-X","article-title":"Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls","volume":"359","author":"Pocock","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mbs.2026.109830_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030215","article-title":"Proposals on Kaplan\u2013Meier plots in medical research and a survey of stakeholder views: KMunicate","volume":"9","author":"Morris","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.mbs.2026.109830_bib0023","first-page":"393","article-title":"Clinical use of the oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer","volume":"9","author":"McVeigh","year":"2017","journal-title":"Breast Cancer"},{"issue":"5","key":"10.1016\/j.mbs.2026.109830_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaf079","article-title":"Mammaprint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX registry real-world data","volume":"9","author":"Brufsky","year":"2025","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.mbs.2026.109830_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12920-015-0129-6","article-title":"Development and verification of the PAM50-based Prosigna breast cancer gene signature assay","volume":"8","author":"Wallden","year":"2015","journal-title":"BMC Med. Genom."},{"issue":"4","key":"10.1016\/j.mbs.2026.109830_bib0026","doi-asserted-by":"crossref","first-page":"897","DOI":"10.21037\/tcr-21-1920","article-title":"A narrative review of five multigenetic assays in breast cancer","volume":"11","author":"Zeng","year":"2022","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.mbs.2026.109830_bib0027","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cpt.1951","article-title":"Artificial intelligence and mechanistic modeling for clinical decision making in oncology","volume":"108","author":"Benzekry","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.mbs.2026.109830_bib0028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1200\/CCI.19.00133","article-title":"Machine learning and mechanistic modeling for prediction of metastatic relapse in early-stage breast cancer","volume":"4","author":"Nicol\u00f2","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"issue":"4","key":"10.1016\/j.mbs.2026.109830_bib0029","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41416-020-01122-x","article-title":"Deep learning in cancer pathology: a new generation of clinical biomarkers","volume":"124","author":"Echle","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.mbs.2026.109830_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41591-023-02643-7","article-title":"A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer","volume":"30","author":"Amgad","year":"2024","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.mbs.2026.109830_bib0031","doi-asserted-by":"crossref","first-page":"E2970","DOI":"10.1073\/pnas.1717139115","article-title":"Predicting cancer outcomes from histology and genomics using convolutional networks","volume":"115","author":"Mobadersany","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.mbs.2026.109830_bib0032","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ccell.2022.07.004","article-title":"Pan-cancer integrative histology-genomic analysis via multimodal deep learning","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0033","first-page":"93","article-title":"Advances in breast cancer care: the role of artificial intelligence and digital pathology in precision medicine","volume":"21","author":"Dur Karasayar","year":"2025","journal-title":"Eur. J. Breast Health"},{"key":"10.1016\/j.mbs.2026.109830_bib0034","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1038\/s41598-025-85323-5","article-title":"Breast cancer prediction based on gene expression data using interpretable machine learning techniques","volume":"15","author":"Kallah-Dagadu","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mbs.2026.109830_bib0035","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232780","article-title":"AsymMirai: interpretable mammography-based deep learning model for 1\u20135-year breast cancer risk prediction","volume":"310","author":"Donnelly","year":"2024","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.mbs.2026.109830_bib0036","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","article-title":"Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead","volume":"1","author":"Rudin","year":"2019","journal-title":"Nat. Mach. Intell."},{"issue":"1","key":"10.1016\/j.mbs.2026.109830_bib0037","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12911-020-01332-6","article-title":"Explainability for artificial intelligence in healthcare: a multidisciplinary perspective","volume":"20","author":"Amann","year":"2020","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.mbs.2026.109830_bib0038","unstructured":"D. Food, U. S. and Administration, 510(k) substantial equivalence determination decision summary: ArteraAI Breast (K254115), 2026, (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K254115.pdf). Decision date 4 May 2026; accessed 21 September 2026."},{"key":"10.1016\/j.mbs.2026.109830_bib0039","article-title":"Mathematical Oncology","volume":"vol. 62","author":"Chaplain","year":"2025"},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/jtbi.2000.1075","article-title":"A dynamical model for the growth and size distribution of multiple metastatic tumors","volume":"203","author":"Iwata","year":"2000","journal-title":"J. Theor. Biol."},{"issue":"5","key":"10.1016\/j.mbs.2026.109830_bib0041","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/09622802211072496","article-title":"Estimating latent, dynamic processes of breast cancer tumour growth and distant metastatic spread from mammography screening data","volume":"31","author":"Gasparini","year":"2022","journal-title":"Stat. Methods Med. Res."},{"issue":"8","key":"10.1016\/j.mbs.2026.109830_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003800","article-title":"Classical mathematical models for description and prediction of experimental tumor growth","volume":"10","author":"Benzekry","year":"2014","journal-title":"PLOS Comput. Biol."},{"key":"10.1016\/j.mbs.2026.109830_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1363144","article-title":"A review of mechanistic learning in mathematical oncology","volume":"15","author":"Metzcar","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.mbs.2026.109830_bib0044","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11538-026-01744-x","article-title":"How AI can advance mathematical biology: opportunities, challenges, and future directions","volume":"88","author":"Rabiei","year":"2026","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.mbs.2026.109830_bib0045","series-title":"Cancer Challenges. Handbook of Cancer and Immunology","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-3-032-00775-9_334","article-title":"Challenges in computational pathology of biomarker-driven predictive and prognostic immunotherapy","volume":"vol. 10","author":"P\u00e9rez-Vel\u00e1zquez","year":"2025"},{"issue":"3421","key":"10.1016\/j.mbs.2026.109830_bib0046","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast","volume":"133","author":"Paget","year":"1889","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mbs.2026.109830_bib0047","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2019seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"7403","key":"10.1016\/j.mbs.2026.109830_bib0048","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mbs.2026.109830_bib0049","article-title":"The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun."},{"issue":"7748","key":"10.1016\/j.mbs.2026.109830_bib0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41586-019-1007-8","article-title":"Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups","volume":"567","author":"Rueda","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mbs.2026.109830_bib0051","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12874-018-0482-1","article-title":"DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network","volume":"18","author":"Katzman","year":"2018","journal-title":"BMC Med. Res. Methodol."},{"issue":"129","key":"10.1016\/j.mbs.2026.109830_bib0052","first-page":"1","article-title":"Time-to-event prediction with neural networks and Cox regression","volume":"20","author":"Kvamme","year":"2019","journal-title":"J. Mach. Learn. Res."},{"issue":"3","key":"10.1016\/j.mbs.2026.109830_bib0053","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4161\/cc.8.3.7608","article-title":"Does the cell number 109 still really fit one gram of tumor tissue?","volume":"8","author":"Del Monte","year":"2009","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.mbs.2026.109830_bib0054","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2","article-title":"On the growth rates of human malignant tumors: implications for medical decision making","volume":"65","author":"Friberg","year":"1997","journal-title":"J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.mbs.2026.109830_bib0055","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast cancer follow-up and management after primary treatment: american society of clinical oncology clinical practice guideline update","volume":"31","author":"Khatcheressian","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0056","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.mbs.2026.109830_bib0057","first-page":"290","article-title":"Breast cancer\u2014major changes in the american joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA: Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.mbs.2026.109830_bib0058","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.mbs.2026.109830_bib0059","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group","volume":"113","author":"Nielsen","year":"2021","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.mbs.2026.109830_bib0060","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.26031","article-title":"The seed and soil hypothesis revisited\u2014the role of tumor-stroma interactions in metastasis to different organs","volume":"128","author":"Langley","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0061","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12282-018-0914-0","article-title":"Does breast cancer growth rate really depend on tumor subtype? measurement of tumor doubling time using serial ultrasonography between diagnosis and surgery","volume":"26","author":"Nakashima","year":"2019","journal-title":"Breast Cancer"},{"issue":"15","key":"10.1016\/j.mbs.2026.109830_bib0062","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1002\/cam4.3939","article-title":"Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review","volume":"10","author":"Dahan","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.mbs.2026.109830_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.70721","article-title":"Estimation of subtype-specific tumour growth rate distributions and interval cancer proportions in breast cancer using biology-inspired natural history models","author":"Orsini","year":"2026","journal-title":"Int. J. Cancer"},{"issue":"18","key":"10.1016\/j.mbs.2026.109830_bib0064","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mbs.2026.109830_bib0065","first-page":"185","article-title":"Asymptotically efficient rank invariant test procedures","volume":"135","author":"Peto","year":"1972","journal-title":"J. R. Stat. Soc.: A"},{"issue":"478","key":"10.1016\/j.mbs.2026.109830_bib0066","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1198\/016214507000000149","article-title":"Evaluating prediction rules for t-Year survivors with censored regression models","volume":"102","author":"Uno","year":"2007","journal-title":"J. Am. Stat. Assoc."},{"issue":"6","key":"10.1016\/j.mbs.2026.109830_bib0067","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/ijc.33704","article-title":"Lymph node metastases in breast cancer: investigating associations with tumor characteristics, molecular subtypes and polygenic risk score using a continuous growth model","volume":"149","author":"Isheden","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.mbs.2026.109830_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012088","article-title":"Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment","volume":"20","author":"Benzekry","year":"2024","journal-title":"PLOS Comput. Biol."},{"issue":"3","key":"10.1016\/j.mbs.2026.109830_bib0069","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jnci\/djab202","article-title":"The incidence of breast cancer recurrence 10\u201332 years after primary diagnosis","volume":"114","author":"Pedersen","year":"2022","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"9","key":"10.1016\/j.mbs.2026.109830_bib0070","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00330-014-3256-0","article-title":"Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound","volume":"24","author":"Ryu","year":"2014","journal-title":"Eur. Radiol."},{"issue":"37","key":"10.1016\/j.mbs.2026.109830_bib0071","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004874","article-title":"Tumor growth rate of invasive breast cancers during wait times for surgery assessed by ultrasonography","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.mbs.2026.109830_bib0072","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.12659\/MSM.901566","article-title":"Correlation factors analysis of breast cancer tumor volume doubling time measured by 3D-ultrasound","volume":"23","author":"Zhang","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"7","key":"10.1016\/j.mbs.2026.109830_bib0073","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1007\/s00330-024-11342-x","article-title":"Tumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population","volume":"35","author":"Nanaa","year":"2025","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.mbs.2026.109830_bib0074","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-026-04419-0","article-title":"Clinical and pathologic insights into early and late breast cancer relapses: a real-world analysis from the El Alamo IV registry","author":"Fraile-Lara","year":"2026","journal-title":"Clin. Transl. Oncol."}],"container-title":["Mathematical Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556426002208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556426002208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:51:41Z","timestamp":1792824701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025556426002208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":74,"alternative-id":["S0025556426002208"],"URL":"https:\/\/doi.org\/10.1016\/j.mbs.2026.109830","relation":{},"ISSN":["0025-5564"],"issn-type":[{"value":"0025-5564","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mechanistic learning framework for breast cancer relapse prediction","name":"articletitle","label":"Article Title"},{"value":"Mathematical Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbs.2026.109830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109830"}}